Skip to main content

Palliative Care as the Standard of Care for Stem Cell Transplants



Today was a big day for palliative care.  Really big.  Why?   Because today we have the strongest evidence to date that integrating specialized palliative care into usual care not only helps those individuals with life-liming diseases like metastatic lung cancer, but also those undergoing potentially curative therapies.

In todays JAMA, El-Jawahri and colleagues describe a single-center randomized clinical trial of 160 adults hospitalized for hematopoietic stem cell transplantation.   These individuals either received specialist palliative care integrated along with usual transplant care or just usual transplant care.  Those assigned to palliative were seen by palliative care clinicians at least twice per week during hospitalization, with the focus primarily on addressing physical and psychological symptoms.

The usual course of stem cell transplant is one that includes worsened quality of life, increased symptom burden, and worsening mood, all of which were seen in the usual care group over the course of 2 weeks.  However, those assigned to palliative care had a smaller decrease in quality of life from baseline to week 2 compared with the usual care group.  These patients also had less depression, anxiety, and symptom burden during this time.  What is also impressive is that caregivers of patients receiving palliative care had a lower increase in mean depression scores in the first two weeks (although no significant change in quality of life).

Three months after the stem cell transplant, patients in the palliative care group had higher quality of life scores and less depression symptoms than those assigned to usual care, although there was no significant differences in anxiety, fatigue, or symptom burden.

To turn these results into a change in clinical practice is going to take a fair amount of leg work.  As I mentioned in an editorial the I co-wrote with Preeti Melani, the current state of palliative care integration in the care of stem cell transplant patients is pretty much summed up with the finding that only two individuals in the control group received formal consultation despite a protocol that allowed patients, caregivers, or transplant clinicians to request palliative care involvement.   This argues that having palliative care just available for consultation may not be enough, rather we should be striving to make it a normal part of the stem cell transplant standard of care.

by: Eric Widera (@ewidera)

Here are the links to the palliative care articles published in this weeks JAMA, which includes a systematic review on palliative care:



Comments

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Survival from severe sepsis: The infection is cured but all is not well

Severe sepsis is a syndrome marked by a severe infection that results in the failure of at least one major organ system: For example, pneumonia complicated by kidney failure. It is the most common non-cardiac cause of critical illness and is associated with a high mortality rate.

But what happens to those who survive their hospitalization for severe sepsis? An important study published in JAMA from Iwashyna and colleagues provides answers and tells us all is not well. When the patient leaves the hospital, the infection may be cured, but the patient and family will need to contend with a host of major new functional and cognitive deficits.

Iwashyna examined disability and cognitive outcomes among 516 survivors of severe sepsis. These subjects were Medicare enrollees who were participants in the Health and Retirement Study. The average age of patients was 77 years.

When interviewed after discharge, most survivors were left with major new deficits in their ability to live independently. …